Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease
References (31)
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
Lancet
(1994)- et al.
Cardiovascular disease risk profiles
Am Heart J
(1991) - et al.
High density lipoprotein as a protective factor against coronary heart disease
Am J Med
(1977) - et al.
The variability of serum cholesterol measurements: implications for screening and monitoring
J Clin Epidemiol
(1990) - et al.
Serum cholesterol, lipoproteins, and the risk of coronary heart disease
Ann Intern Med
(1971) The lipid research clinics coronary primary prevention trial results 1: reduction in incidence of coronary heart disease
JAMA
(1984)- et al.
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study
JAMA
(1988) - et al.
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
BMJ
(1994) - et al.
Dietary reduction of serum cholesterol concentration: time to think again
BMJ
(1991) - et al.
Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials
BMJ
(1990)
An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence
Circulation
(1990)
Cholesterol lowering and mortality: the importance of considering initial level of risk
BMJ
(1993)
Lower patient's cholesterol now
BMJ
(1995)
Discontinuation of antihyperlipidaemic drugs-do rates reported in clinical trials reflect rates in primary care settings?
N Engl J Med
(1995)
The UK-TIA Aspirin Trial: the interim results
BMJ
(1988)
Cited by (0)
Copyright © 1995 Published by Elsevier Ltd.